Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine.
RedHill Biopharma's antibiotic succeeds in late-stage study
![RedHill Biopharma's antibiotic succeeds in late-stage study]()
Reviewed by jenisht
on
December 03, 2018
Rating:
No comments: